Abstract:Background and objective: The growing problem of drug resistance among respiratory pathogens in community-acquired pneumonia (CAP), particularly Streptococcus pneumoniae, (S. pneumoniae) has complicated initial empiric therapy of CAP. This study was undertaken to evaluate the efficacy and tolerability of a 3-day course of azithromycin in adults with mild to moderately severe CAP, and to determine whether in vitro macrolide resistance among strains of S. pneumoniae is related to clinical efficacy/failure. Methods: An open-label, non-comparative study was undertaken at 3 university-affiliated hospitals in Japan. Patients were eligible if they were 18 years or older and had mild or moderately severe CAP. All patients received azithromycin 500 mg/day for three days, and clinical and microbiological responses were evaluated 1 and 2 weeks after initiating therapy. Results: A total of 78 patients received the study medication, 59 of whom had sufficient data available for efficacy analysis. Overall, a good clinical response with azithromycin was achieved in 49 patients (83.1%) and a microbiological response was achieved in 78.3%. Azithromycin resistance, based on CLSI criteria, was demonstrated in 85.7% (12/14) of S. pneumoniae isolates, and the presence of ermB genes was found in 50.0% (7/14). However, among patients in whom S. pneumoniae was isolated (n=17), a good clinical response was achieved in 76.5% (13/17), and the microbiological response rate was 64.3% (9/14). Furthermore, 6 of 7 patients in whom high-level resistance was documented (MICs >256 microg/mL and carrying ermB genes) exhibited good clinical responses. Azithromycin was well tolerated; adverse events, mainly of a gastrointestinal nature, were recorded in 6 patients (7.7%). Conclusion: Most patients responed well to azithromycin, indicating that azithromycin might be clinically effective for the treatment of CAP with macrolide-resistant S. pneumoniae. However, a larger study is necessary to prove the efficacy against macrolide-resistant S. pneumoniae.

Multicenter Clinical Evaluation of Domestic Azithromycin Injection in the Treatment of Bacterial Infections

Clinical evaluation of azithromycin

Clinical Comparative Study of Injectable Azithromycin and Cefuroxime in the Treatment of Lower Respiratory Tract Infection

A Randomized Controlled Clinical Trial on Injective Azithromycin Versus Erythromycin in the Treatment of Respiratory Tract Bacterial Infections.

The Efficacy and Safety of Azithromycin in Acute Community-Acquired Low Respiratory Infection

Clinical evaluation of azithromycin sequential therapy in the treatment of 138 patients with community-acquired pneumonia

A randomized, controlled, single blinded clinical study on domestic versus imported ceftizoxime sodium for injection in the treatment of acute bacterial infections

Clinical trial and nursing care of patients with respiratory tract infection treated with domestic cefmetazole sodium for injection

A Multicenter Clinical Study on Self-Manufactured Versus Imported Ceftizoxime for Injection in Treatment of Acute Bacterial Respiratory Tract Infectious

A randomized multicenter clinical study of injectable levofloxacin in the treatment of acute bacterial infections

The multi-center clinical study of etimicin injection against acute bacterial infections

The Efficacy and Safety of Azithromycin in Asthma: A Systematic Review

Multi-center, randomized, blinded, parallel control clinical study of cefazedone injection and cefazolin injection in the treatment of acute bacterial respiratory infections

A Randomized Multicenter Clinical Study of Cefpodoxime Proxetil Tablets in Treatment of Acute Bacterial Infections in 158 Patients

Clinical Efficacy of Azithromycin in Treatment of Children’s Mycoplasma Pneumonia

Bioequivalence of Domestic Azithromycin Granules in Healthy Volunteers

A clinical randomized controlled trial of pazufloxacin injection in treatment of bacterial infection in 111 patients

Clinical Randomized Controlled Trial of Amoxycillin-sulbactam Injection in the Treatment of Bacterial Infection

Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection

Clinical Study of Cefprozil in Treatment of Respiratory Tract Infections

Clinical Efficacy of Azithromycin in the Treatment of Pediatric Mycoplasma pneumoniae Pneumonia and Its Impact on Platelet Count and D-Dimer Levels